Zydus Lifesciences Ltd.

Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for an inspection conducted at its manufacturing facility located at Baddi, from August 4, 2025 to August 13, 2025. The EIR has classified the facility as Voluntary Action Indicated (VAI). The USFDA has concluded this inspection as closed. 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.